| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Aselage Steve is a Director at Travere Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $8.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2016 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 8,200 | $21.12 | $173,160.00 | -1.7% | |
| Nov 10, 2015 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 60,000 | $18.75 | $1,124,700.00 | -8.5% |